This paper is in the following e-collection/theme issue:

Pharmacovigilance (154) Demographics of Users, Social & Digital Divide (822) Cyberpharmacies (54) Pharmacology and Pharmaceutics (84) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (177) Clinical Informatics (1126) Sleep Medicine (30) Sleep Monitoring, Sleep Quality, Sleep Disorders (218) Neurology and Neurosciences (218)

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/53957, first published .
Trends in Prescription of Stimulants and Narcoleptic Drugs in Switzerland: Longitudinal Health Insurance Claims Analysis for the Years 2014-2021

Trends in Prescription of Stimulants and Narcoleptic Drugs in Switzerland: Longitudinal Health Insurance Claims Analysis for the Years 2014-2021

Trends in Prescription of Stimulants and Narcoleptic Drugs in Switzerland: Longitudinal Health Insurance Claims Analysis for the Years 2014-2021

Authors of this article:

Tamara Scharf1, 2, 3 Author Orcid Image ;   Carola A Huber4, 5 Author Orcid Image ;   Markus Näpflin4 Author Orcid Image ;   Zhongxing Zhang3, 6 Author Orcid Image ;   Ramin Khatami3, 6, 7 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
Shoaib Alam Shoaib Alam @ShoaibAlamKhat2

Out in @jmirpub: Stimulant prescriptions rose modestly (0.55% → 0.81%), highlighting unmet needs for #ADHD & hypersomnolence care. 37% of prescriptions came from psychiatrists, with 5.3x higher odds of psychiatric hospitalization in users. #PublicHealth https://t.co/DJ1LqUnrAf

9:32 PM · Jan 11, 2025

0
0
JMIR Publications JMIR Publications @jmirpub

RT @ShoaibAlamKhat2: Out in @jmirpub: Stimulant prescriptions rose modestly (0.55% → 0.81%), highlighting unmet needs for #ADHD & hypersom…

3:02 PM · Jan 13, 2025

1
1